AstraZeneca Pharma India Limited has informed the Exchange about AstraZeneca Pharma India Limited has received an Import and Market permission in Form CT-20 (Subsequent New Drug Approval) from the Central Drugs……
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
